The expression of neuron-type glutamate transporters (EAAC-1), AMPA glutamate receptor subunits (GluR1 and GluR2/3), polyadenosine (5'diphosphate-ribose) polymerase (PARP), and transforming growth factor-β1 was investigated in 20 cases of neonatal pontosubicular neuron necrosis and 12 gestational-age matched controls. Developmental immunoreactivities of EAAC-1, GluR1, and GluR2/3 appeared in the neurons of the pontine nuclei at 29 to 30 weeks' gestation in controls, and then gradually increased with age. However, these activities were decreased in the pontine nucleus of patients with pontosubicular neuron necrosis. Decreases in these immunoreactivities might indicate early degeneration of neurons. Although PARP and transforming growth factor-β1 immunoreactivity was insignificant or very weak in the pontine nuclei at any age in controls, PARP was markedly expressed in karyorrhectic neurons of the pontine nucleus in patients with pontosubicular neuron necrosis. Transforming growth factor-β1 immunoreactivity was observed in nonkaryorrhectic neurons of the pontine nuclei. PARP could contribute to the pathogenesis of pontosubicular neuron necrosis more than EAAC-1 or GluR1 or GluR2/3. Transforming growth factor-β1 could play a role in the protection and repair of damaged neurons. (J Child Neurol 2000;15:362-369).
Get full access to this article
View all access options for this article.
References
1.
Fride RL: Perinatal lesions of gray matter, in Fride RL: Developmental Neuropathology , 2nd ed. Berlin, Springer Verlag,1989, pp 90-92.
2.
Mito T., Kamei A., Takashima S., Becker LE: Clinicopathological study of pontosubicular necrosis. Neuropediatrics1993;24: 204-207.
3.
Ozawa H., Fukuda T., Nishida A., Takashima S.: Cu, Zn-superoxide dismutase reaction in neonatal pontosubicular neuron necrosis . Pediatr Neurol1997;16:126-130.
4.
Sohma O., Mito T., Mizuguchi M., Takashima S.: The prenatal age critical for the development of pontosubicular necrosis. Acta Neuropathol1995;90:7-10.
5.
Ozawa H., Nishida A., Mito T., Takashima S.: Ferritin immunohistochemical study on infants with pontosubicular necrosis . Brain Dev1995;17:20-23.
6.
Bruck Y., Bruck W., Kretzschmar HA, Lassmann H.: Evidence for neuronal apoptosis in pontosubicular neuron necrosis. Neuropathol Appl Neurobiol1996;22:23-29.
7.
Scott RJ, Hegyi L.: Cell death in perinatal hypoxic-ischemic brain injury. Neuropathol Appl Neurobiol1997;23:307-314.
8.
Rothstein JD , Dykes-Hoberg M., Pardo CA, et al: Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron1996;16: 675-686.
9.
Smith DH, Chen XH, Pierce Jes, et al: Progressive atrophy and neuronal death for one year following brain trauma in the rat. J Neurotrauma1997 ;14:715-727.
10.
Rothstein JD , Martin LJ, Levey AI, et al: Localization of neuronal and glial glutamate transporters. Neuron1994;13:713-725.
11.
Chaudhry FA , Lehre KP, Campagne Mvl, et al: Glutamate transporters in glial plasma membranes: Highly differentiated localization revealed by quantitative ultrastructural immunocytochemistry. Neuron1995;15:717-720.
12.
Martin LJ, Brambrink AM, Lehmann C., et al: Hypoxia-ischemia causes abnormalities in glutamate transporters, and death of astroglia and neurons in the newborn striatum. Ann Neurol1997; 42:335-348.
13.
Inage YW, Itoh M., Wada K., Takashima S.: Expression of two glutamate transporters, GLAST and EAAT-4, in the human cerebellum: Their correlation in development and neonatal hypoxic-ischemic damage. J Neuropathol Exp Neurol1998;57:554-562.
14.
Pellegrini-Giampietro DE, Zukin RS, Bennett Mvl, et al: Switch in glutamate receptor subunit gene expression in the CA1 subfield of the hippocampus following global ischemia in rats. Proc Natl Acad Sci U S A1992 ;89:10499-10503.
15.
Frank L., Diemer NH, Kaiser F., et al: Unchanged balance between levels of mRNA encoding AMPA glutamate receptor subtypes following global cerebral ischemia in the rat. Acta Neurol Scand1995;92:337-343.
16.
Paschen W., Schmitt J., Uto A.: RNA editing of glutamate receptor subunits GluR2, GluR5, and GluR6 in transient cerebral ischemia in the rat. J Cereb Blood Flow Metab1996;16:538-556.
17.
Zhang J., Dawson VL, Dawson TM, Snyder SH: Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Science1994;263:687-689.
18.
Cosi C., Suzuki H., Milani D., et al: Poly (ADP-ribose) polymerase: Early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells. J Neurosci Res1994;38:38-46.
19.
Love S., Barber S., Wilcock GK: Apoptosis and expression of DNA repair proteins in ischemic brain injury in man. Neuroreport1998; 9:955-959.
20.
Endres M., Wang ZQ, Namura S., et al: Ischemic brain injury is mediated by the activation of poly (ADP-ribose) polymerase. J Cereb Blood Flow Metab1997;17:1143-1151.
21.
Tokime T., Nozaki K., Sugino T., et al: Enhanced poly (ADP-ribosyl) ation after focal ischemia in rat brain. J Cereb Blood Flow Metab1998;18:991-997.
22.
Eliasson Mjl , Sampei K., Mandir AS, et al: Poly (ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med1997;3:1089-1095.
23.
Flanders KC , Ludecke G., Engels S.: Localization and action of transforming growth factor betas in the embryonic nervous system. Development1991;113:183-191.
24.
Unsicker K. , Flanders KC, Cissel DS, et al: Transforming growth factor beta isoforms in the adult rat central and peripheral nervous systems. Neurosci1991;44:613-625.
25.
Wiebner C., Gehrmann J., Lindholm D., et al: Expression of transforming growth factor-β1 and interleukin-1β mRNA in rat brain following transient forebrain ischemia. Acta Neuropathol1993; 86:439-446.
26.
Lehrmann E. , Kiefer R., Finsen B., et al: Cytokines in cerebral ischemia: Expression of transforming growth factor beta-1 (transforming growth factor-β1) mRNA in the postischemic adult rat hippocampus. Exp Neurol1995;131:114-123.
27.
Wang XW, Yue TL, White RF, et al: Transforming growth factor-β1 exhibits delayed gene expression following focal cerebral ischemia. Brain Res Bull1995;36:607-609.
28.
Kunckey NW, Finch P., Palm DE, et al: Differential neuronal and astrocytic expression of transforming growth factor beta isoforms in rat hippocampus following transient forebrain ischemia. Mol Brain Res1996;40:1-14.
29.
Klempt ND, Sirimanne E., Gunn AJ: Hypoxia-ischemia induces transforming growth factor-β1 mRNA in the infant rat brain. Mol Brain Res1992;13:93-101.
30.
Gross CE, Bednar MM, Howard DB, Sporn MB: Transforming growth factor-β1 reduces the infarct size after experimental cerebral ischemia in a rat model. Stroke1993 ;24:558-562.
31.
McNeill H., Williams C., Guan J., et al: Neuronal rescue with transforming growth factor-β1 after hypoxic-ischemic brain injury. Neuroreport1994;5:901-904.
32.
Hoffman B., Lieberma DA: Molecular controls of apoptosis: Differentiation/growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene1994;9:1807-1812.
33.
Kato M., Mizuguchi M., Takashima S.: Developmental changes of heat shock protein 73 in the human brain. Dev Brain Res1995;86: 180-186.
34.
Hollman M., Hartley M., Heinemann S.: Ca2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science1991;252:851-853.
35.
Keller B., Hollmann M., Heinemann S., Konnerth A.: Calcium influx through subunits GluR1/GluR3 of kainate/AMPA receptor channels is regulated by cAMP-dependent protein kinase. EMBO J1992;11:891-896.
36.
Sommer B., Kohler M., Sprengel R.: RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell1991; 67:11-19.
37.
Pellegrini-Giampietro DE, Gorter JA, Bennett MV, Zukin RS: The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurol1997;20:464-470.
38.
Meng SZ, Ohyu J., Takashima S.: Changes in AMPA glutamate and dopamine D2 receptors in hypoxic-ischemic basal ganglia necrosis. Pediatr Neurol1997;17:139-143.
39.
Gottlieb M., Matute C.: Expression of ionotropic glutamate receptor subunits in glial cells of the hippocampal CA1 area following transient forebrain ischemia. J Cereb Flow Blood Metab1997;17: 290-300.
40.
Gaal JC, Smith KR, Pearson CK: Cellular euthanasia mediated by a nuclear enzyme: A central role for nuclear ADP-ribosylation in cellular metabolism. Trends BiolSci1987;12:129-130.
41.
De Murcia G. , De Murcia GM: Poly (ADP-ribose) polymerase: A molecular nick sensor. Trends Biol Sci1994;19:172-176.
42.
Patel T., Gores GJ, Kaufmann SH: The role of proteases during apoptosis. FASEB J1996;10:587-597.
43.
Yoon YS, Kim JM, Kang KW, et al: Poly (ADP-ribosyl) ation of his-tone H1 correlates with internucleosomal DNA fragmentation during apoptosis. J Biochem1996;271:9129-9134.
44.
Rosenthal DS , Ding R., Simbulan-Rosenthal Cmg, et al: Intact cell evidence for the early synthesis, and subsequent late apopain-mediated suppression, of poly (ADP-ribose) during apoptosis. Exp Cell Res1997;232:313-321.
45.
Simbulan-Rosenthal CM, Rosenthal DS, Iyer S., et al: Transient poly (ADP-ribosyl)ation of nuclear proteins and role of poly (ADPribose) polymerase in the early stages of apoptosis. J Biochem1998;273:13703-13712.
46.
Lazebnik YA , Kaufmann SH, Desnoyers S., et al: Cleavage of poly (ADP-ribose) polyomerase by a proteinase with properties like ICE. Nature1994;371:346-350.
